A multicenter, postmarketing study to evaluate the concentration of certolizumab pegol in the breast milk of mothers receiving treatment with Cimzia® (certolizumab pegol) (CRADLE)

24/06/2014
02/07/2024
EU PAS number:
EUPAS6785
Study
Finalised
Documents
Study protocol
Study results
Study results
English (121.01 KB - PDF) View document
Study report
Other information